For Risk-Tolerant Investors, Lyell Immunopharma Inc (NASDAQ: LYEL) Stands Out As A Strong Investment Choice
During the last session, Lyell Immunopharma Inc (NASDAQ:LYEL)’s traded shares were 0.62 million, with the beta value of the company hitting -0.34. At the end